KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Cash & Current Investments (2018 - 2025)

Castle Biosciences (CSTL) has disclosed Cash & Current Investments for 8 consecutive years, with $299.5 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 2.16% to $299.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $299.5 million through Dec 2025, up 2.16% year-over-year, with the annual reading at $299.5 million for FY2025, 2.16% up from the prior year.
  • Cash & Current Investments hit $299.5 million in Q4 2025 for Castle Biosciences, up from $287.6 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $407.0 million in Q1 2021 to a low of $225.5 million in Q2 2023.
  • Historically, Cash & Current Investments has averaged $285.8 million across 5 years, with a median of $275.5 million in 2025.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 312.54% in 2021 and later dropped 26.76% in 2022.
  • Year by year, Cash & Current Investments stood at $329.6 million in 2021, then fell by 21.54% to $258.6 million in 2022, then decreased by 6.0% to $243.1 million in 2023, then rose by 20.58% to $293.1 million in 2024, then rose by 2.16% to $299.5 million in 2025.
  • Business Quant data shows Cash & Current Investments for CSTL at $299.5 million in Q4 2025, $287.6 million in Q3 2025, and $275.9 million in Q2 2025.